000			02031 a2200601 4500
005			20250515100720.0
264		0	_c20080131
008			200801s 0 0 eng d
022			_a1473-5571
024	7		_a10.1097/QAD.0b013e3282f2306e _2doi
040			_aNLM _beng _cNLM
100	1		_aHoffmann, Christopher J
245	0	0	_aAntiretroviral therapy using zidovudine, lamivudine, and efavirenz in South Africa: tolerability and clinical events. _h[electronic resource]
260			_bAIDS (London, England) _cJan 2008
300			_a67-74 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAlkynes
650	0	4	_aAnemia
650	0	4	_aAnti-HIV Agents _xadverse effects
650	0	4	_aAntiretroviral Therapy, Highly Active
650	0	4	_aBenzoxazines _xtherapeutic use
650	0	4	_aCohort Studies
650	0	4	_aCyclopropanes
650	0	4	_aDeveloping Countries
650	0	4	_aDizziness _xchemically induced
650	0	4	_aDrug Tolerance
650	0	4	_aFemale
650	0	4	_aHIV Infections _xdrug therapy
650	0	4	_aHIV-1
650	0	4	_aHumans
650	0	4	_aLamivudine _xtherapeutic use
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNausea _xchemically induced
650	0	4	_aNeutropenia _xchemically induced
650	0	4	_aProspective Studies
650	0	4	_aSouth Africa
650	0	4	_aTreatment Outcome
650	0	4	_aViral Load
650	0	4	_aVomiting _xchemically induced
650	0	4	_aZidovudine _xtherapeutic use
700	1		_aFielding, Katherine L
700	1		_aCharalambous, Salome
700	1		_aSulkowski, Mark S
700	1		_aInnes, Craig
700	1		_aThio, Chloe L
700	1		_aChaisson, Richard E
700	1		_aChurchyard, Gavin J
700	1		_aGrant, Alison D
773	0		_tAIDS (London, England) _gvol. 22 _gno. 1 _gp. 67-74
856	4	0	_uhttps://doi.org/10.1097/QAD.0b013e3282f2306e _zAvailable from publisher's website
999			_c17603059 _d17603059